NERPHARMA

NerPharMa is a CDMO with a strong expertise in Oncology, bringing highly potent compounds, new products and unique innovative technologies to the market delivering a wide range of GMP services. NerPharMa owns a wide and cutting-edge organizational structure able to ensure the API full development and production (in NerPharMa DS division) and finished products (in NerPharMa DP division) intended for the world market, as well as the research and development of innovative formulation and delivery systems, operating in accordance with cGMP and are authorized by the most relevant authorities: AIFA, FDA, ANVISA Brazil, China FDA, PMDA Japan and Russia.